Chronic kidney disease trials in Spain
45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleInternational (Pediatric) Peritoneal Biobank
- Where
- Barcelona
- Age
- 1 day to 90 years
- People
- 500 worldwide
- Run by
- Heidelberg University
See details and how to joinNCT01893710 - Phase 3Enrolling by invitationFINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
- Where
- A Coruña, Badalona, Barcelona, Getafe, Madrid, Majadahonda, Pamplona, Sevilla, Valencia
- Age
- 18 years and over
- People
- 180
- Run by
- University Medical Center Groningen
See details and how to joinNCT07181135 · EU 2025-523075-32-00 - Phase 3Taking peopleEfficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Where
- A Coruña, Badalona, Barcelona, Girona, Madrid, Oviedo
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Iperboreal Pharma Srl
See details and how to joinNCT03994471 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Barcelona, Córdoba, Getafe, L'hospitalet De Llobregat, Madrid, Sevilla, Valencia
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - Phase 3Taking peopleA Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
- Where
- Albacete, Alcorcón, Burgos, Córdoba, Leganés, Valencia
- Age
- 70 years and over
- People
- 94
- Run by
- Fundación para la Investigación del Hospital Clínico de Valencia
See details and how to joinNCT06578078 · EU 2024-513971-42-00 - No phaseTaking peopleClinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
- Where
- Valencia
- Age
- 18 years to 90 years
- People
- 250
- Run by
- Cardenal Herrera University
See details and how to joinNCT07309094 - Phase 2Taking peopleSafety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
- Where
- Barcelona, Santa Cruz de Tenerife
- People
- 28 worldwide
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
See details and how to joinNCT04580420 - Phase 4Enrolling by invitationUrinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- Where
- Madrid
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT06954090 · EU 2024-518682-95-00 - No phaseTaking peopleA Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
- Where
- Barakaldo, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
- Age
- 18 years and over
- People
- 10 worldwide
- Run by
- Takeda
See details and how to joinNCT06243731 - Phase 4Taking peopleA Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- Where
- Valencia
- Age
- 18 years to 75 years
- People
- 125 worldwide
- Run by
- Peter Rossing
See details and how to joinNCT07239570 - No phaseNot yet taking people in SpainPathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol
- Where
- Barcelona
- Age
- 18 years and over
- People
- 3,000
- Run by
- Hospital del Mar
See details and how to joinNCT07208994 - No phaseTaking peopleCreation of Arteriovenous Fistulas for Hemodialysis Using the End-to-side Anastomotic Technique vs. Piggyback.
- Where
- Barcelona
- Age
- 18 years and over
- People
- 130
- Run by
- Hospital Clinic of Barcelona
See details and how to joinNCT06997042 - Phase 4Taking peopleEffectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
- Where
- Madrid
- People
- 114
- Run by
- Instituto de Investigación Hospital Universitario La Paz
See details and how to joinNCT06701825 · EU 2024-516596-32-00 - No phaseTaking peopleFirst-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
- Where
- Madrid
- Age
- 18 years and over
- People
- 12 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT06314503 - Phase 3Taking peopleColchicine in Chronic Kidney Disease Patients
- Where
- Madrid
- Age
- 18 years to 99 years
- People
- 744
- Run by
- Hospital General Universitario Gregorio Marañon
See details and how to joinNCT06998862 · EU 2023-505868-11-00 - No phaseTaking peopleEffects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
- Where
- Madrid
- Age
- 18 years and over
- People
- 104
- Run by
- Universidad Europea de Madrid
See details and how to joinNCT06109493 - No phaseTaking peopleFGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
- Where
- Córdoba
- Age
- 18 years to 85 years
- People
- 401
- Run by
- Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT05356325 - No phaseTaking peopleTreatment of Hypertension During Sleep
- Where
- A Estrada, Nigrán, Ourense, Vigo, Vilagarcía de Arousa
- Age
- 18 years and over
- People
- 5,320
- Run by
- University of Vigo
See details and how to joinNCT03457168 - Phase 3Taking peoplePhase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD)
- Where
- Alicante, Barcelona, Valencia
- Age
- 18 years and over
- People
- 78
- Run by
- Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
See details and how to join2024-517631-43-00 · EU 2024-517631-43-00 - No phaseTaking peopleCoronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure
- Where
- Madrid
- Age
- 18 years to 100 years
- People
- 124
- Run by
- Guillermo Galeote; MD, PhD
See details and how to joinNCT05353946